Search Results - "Ferme, Christophe"

Dissemination patterns of Hodgkin lymphoma using a probability network model based on [18F]-FDG PET/CT by Mouheb, Mehdi, Pierre-Jean, Morgane, Fermé, Christophe, Devillers, Anne, Lamy, Thierry, Le Jeune, Florence, Houot, Roch, Palard-Novello, Xavier

“…Purpose The preferred hypothesis for the dissemination patterns of Hodgkin lymphoma (HL) is the contiguity hypothesis. However, this hypothesis is based on…”
Get full text

CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte by BONNET, Christophe, FILLET, Georges, TILLY, Hervé, REYES, Félix, MOUNIER, Nicolas, GANEM, Gérard, MOLINA, Thierry Jo, THIEBLEMONT, Catherine, FERME, Christophe, QUESNEL, Bruno, MARTIN, Claude, GISSELBRECHT, Christian

“…Chemoradiotherapy has been considered standard treatment for patients with limited-stage aggressive lymphoma on the basis of trials conducted before the…”
Get full text

Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma by Mouheb, Mehdi, Pierre-Jean, Morgane, Devillers, Anne, Fermé, Christophe, Benchalal, Mohamed, Manson, Guillaume, Le Jeune, Florence, Houot, Roch, Palard-Novello, Xavier

“…Purpose We aimed to assess the prognostic value of baseline tumor burden and dissemination parameters extracted from 18 F-FDG PET/CT in patients with early or…”
Get full text

Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study by COIFFIER, Bertrand, MOUNIER, Nicolas, HERBRECHT, Raoul, BOLOGNA, Serge, FERME, Christophe, TILLY, Hervé, SONET, Anne, CHRISTIAN, Bernard, CASASNOVAS, Olivier, JOURDAN, Eric, BELHADJ, Karim

“…Hyperuricemia and tumor lysis syndrome are well-known complications during induction treatment of aggressive non-Hodgkin's lymphomas (NHLs). Usual prophylaxis…”
Get full text

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA by FITOUSSI, Olivier, BELHADJ, Karim, HERBRECHT, Raoul, JANVIER, Maud, VAN DEN NESTE, Eric, MORSCHHAUSER, Franck, CASASNOVAS, Olivier, GHESQUIERES, Hervé, ANGLARET, Bruno, BRECHIGNAC, Sabine, HAIOUN, Corinne, GISSELBRECHT, Christian, MOUNIER, Nicolas, PARRENS, Marie, TILLY, Herve, SALLES, Gilles, FEUGIER, Pierre, FERME, Christophe, YSEBAERT, Loic, GABARRE, Jean

“…As rituximab combined with CHOP improves complete remission and overall survival in diffuse large B-cell lymphoma, intensified chemotherapy followed by…”
Get full text

Low-Dose Radiation Treatment in Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: A Plausible Approach? A Single-Institution Experience in 10 Patients by Girinsky, Theodore, M.D, Paumier, Amaury, M.D, Ferme, Christophe, M.D, Hanna, Colette, M.D, Ribrag, Vincent, M.D, Leroy-Ladurie, François, Ghalibafian, Mithra, M.D

“…Purpose To propose an alternative approach for treatment of pulmonary marginal zone lymphoma, using a very small radiation dose (2 × 2 Gy) delivered…”
Get full text

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte by CASASNOVAS, Rend-Olivier, MOUNIER, Nicolas, BIENVENU, Jacques, GUIGUET, Michel, INTRATOR, Liliane, GRANDJEAN, Monique, BRIERE, Josette, FERME, Christophe, SALLES, Gilles, BRICE, Pauline, DIVINE, Marine, MORSCHHAUSER, Franck, GABARRE, Jean, BLAY, Jean-Yves, VOILLAT, Laurent, LEDERLIN, Pierre, STAMATOULLAS, Aspasia

“…Approximately 15% of patients with localized and 30% with disseminated classical Hodgkin's lymphoma fail to respond or relapse after first-line treatment…”
Get full text

Efficacy and Safety of the Combination of Rituximab, Fludarabine, and Mitoxantrone for Rituximab-Naive, Recurrent/Refractory Follicular Non-Hodgkin Lymphoma With High Tumor Burden: A Multicenter Phase 2 Trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS) by MORSCHHAUSER, Franck, MOUNIER, Nicolas, SEBBAN, Catherine, BRICE, Pauline, SOLAL-CELIGNY, Phillippe, TILLY, Herve, FEUGIER, Pierre, FERME, Christophe, CHRISTINE COPIN, Marie, LAMY, Thierry

“…This phase 2 trial was undertaken to evaluate the efficacy and safety of rituximab combined with intravenous fludarabine and mitoxantrone (R-FM) for patients…”
Get full text

Positive Correlation between Epstein-Barr Virus Viral Load and Anti-Viral Capsid Immunoglobulin G Titers Determined for Hodgkin's Lymphoma Patients and Their Relatives by BESSON, Caroline, AMIEL, Corinne, LE-PENDEVEN, Catherine, BRICE, Pauline, FERME, Christophe, CARDE, Patrice, HERMINE, Olivier, RAPHAEL, Martine, ABEL, Laurent, NICOLAS, Jean-Claude

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

A stage IV Hodgkin lymphoma in a 28-year-old woman by Fermé, Christophe

Get full text

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte by Coiffier, Bertrand, Thieblemont, Catherine, Van Den Neste, Eric, Lepeu, Gérard, Plantier, Isabelle, Castaigne, Sylvie, Lefort, Sophie, Marit, Gérald, Macro, Margaret, Sebban, Catherine, Belhadj, Karim, Bordessoule, Dominique, Fermé, Christophe, Tilly, Hervé

“…We report the outcome of patients included in the LNH-98.5 study, which compared cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) to rituximab…”
Get full text

Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study by Besson, Caroline, Roetynck, Sophie, Williams, Fionnuala, Orsi, Laurent, Amiel, Corinne, Lependeven, Catherine, Antoni, Guillemette, Hermine, Olivier, Brice, Pauline, Ferme, Christophe, Carde, Patrice, Canioni, Danielle, Brière, Josette, Raphael, Martine, Nicolas, Jean-Claude, Clavel, Jacqueline, Middleton, Derek, Vivier, Eric, Abel, Laurent

“…Epstein-Barr virus (EBV) is the major environmental factor associated with Hodgkin's lymphoma (HL), a common lymphoma in young adults. Natural killer (NK)…”
Get full text

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial by André, Marc P E, Girinsky, Théodore, Federico, Massimo, Reman, Oumédaly, Fortpied, Catherine, Gotti, Manuel, Casasnovas, Olivier, Brice, Pauline, van der Maazen, Richard, Re, Alessandro, Edeline, Véronique, Fermé, Christophe, van Imhoff, Gustaaf, Merli, Francesco, Bouabdallah, Réda, Sebban, Catherine, Specht, Lena, Stamatoullas, Aspasia, Delarue, Richard, Fiaccadori, Valeria, Bellei, Monica, Raveloarivahy, Tiana, Versari, Annibale, Hutchings, Martin, Meignan, Michel, Raemaekers, John

“…Purpose Patients who receive combined modality treatment for stage I and II Hodgkin lymphoma (HL) have an excellent outcome. Early response evaluation with…”
Get full text

Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas by Moise, Laura, Matta, Clemence, Hanna, Colette, Pilorge, Sylvain, Fermé, Christophe, Durrbach, Antoine, Ribrag, Vincent

Get full text

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial by Salles, Gilles, Prof, Seymour, John Francis, Prof, Offner, Fritz, Prof, López-Guillermo, Armando, MD, Belada, David, MD, Xerri, Luc, Prof, Feugier, Pierre, Prof, Bouabdallah, Réda, MD, Catalano, John Vincent, FRACP, Brice, Pauline, MD, Caballero, Dolores, MD, Haioun, Corinne, Prof, Pedersen, Lars Moller, MD, Delmer, Alain, Prof, Simpson, David, FRACP, Leppa, Sirpa, MD, Soubeyran, Pierre, Prof, Hagenbeek, Anton, Prof, Casasnovas, Olivier, MD, Intragumtornchai, Tanin, Prof, Fermé, Christophe, MD, da Silva, Maria Gomes, MD, Sebban, Catherine, MD, Lister, Andrew, Prof, Estell, Jane A, FRACP, Milone, Gustavo, MD, Sonet, Anne, MD, Mendila, Myriam, MD, Coiffier, Bertrand, Prof, Tilly, Hervé, Prof

“…Summary Background Patients with follicular lymphoma can have long survival times, but disease progression typically occurs 3–5 years after initial treatment…”
Get full text

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial by Delarue, Richard, Dr, Tilly, Hervé, Prof, Mounier, Nicolas, Prof, Petrella, Tony, MD, Salles, Gilles, Prof, Thieblemont, Catherine, Prof, Bologna, Serge, MD, Ghesquières, Hervé, MD, Hacini, Maya, MD, Fruchart, Christophe, MD, Ysebaert, Loïc, MD, Fermé, Christophe, MD, Casasnovas, Olivier, MD, Van Hoof, Achiel, MD, Thyss, Antoine, Prof, Delmer, Alain, Prof, Fitoussi, Olivier, MD, Molina, Thierry Jo, Prof, Haioun, Corinne, Prof, Bosly, André, Prof

“…Summary Background Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) has become the standard of care…”
Get full text

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial by Récher, Christian, Prof, Coiffier, Bertrand, Prof, Haioun, Corinne, Prof, Molina, Thierry Jo, Prof, Fermé, Christophe, MD, Casasnovas, Olivier, MD, Thiéblemont, Catherine, Prof, Bosly, André, Prof, Laurent, Guy, Prof, Morschhauser, Franck, MD, Ghesquières, Hervé, MD, Jardin, Fabrice, Prof, Bologna, Serge, MD, Fruchart, Christophe, MD, Corront, Bernadette, MD, Gabarre, Jean, MD, Bonnet, Christophe, MD, Janvier, Maud, MD, Canioni, Danielle, Prof, Jais, Jean-Philippe, MD, Salles, Gilles, Prof, Tilly, Hervé, Dr, Prof

“…Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab…”
Get full text

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy by Salles, Gilles Andre, Seymour, John Francis, Feugier, Pierre, Offner, Fritz, Lopez-Guillermo, Armando, Belada, David, Xerri, Luc, Bouabdallah, Reda, Catalano, John, Pauline, Brice, Caballero, Dolores, Haioun, Corinne, Pedersen, Lars Moller, Delmer, Alain, Simpson, David, Leppa, Sirpa, Soubeyran, Pierre, Hagenbeek, Anton, Casasnovas, Olivier, Intragumtornchai, Tanin, Ferme, Christophe, Gomes da Silva, Maria, Sebban, Catherine, Lister, Andrew, Estell, Jane A, Milone, Gustavo, Sonet, Anne, Coiffier, Bertrand, Tilly, Herve

“…▪ The intergroup PRIMA Phase III study was designed to investigate the potential benefit of 2-years of rituximab maintenance in patients with follicular…”
Get full text

Management of fertility in patients treated for Hodgkin’s lymphoma by HAREL, Stephanie, FERME, Christophe, POIROT, Catherine

“…The risk of developing premature ovarian failure and azoospermia is a major concern in long-term survivors treated for Hodgkin's lymphoma. Alkylating…”
Get full text

Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial by RAEMAEKERS, John M. M, ANDRE, Marc P. E, BOUABDALLAH, Reda, SEBBAN, Catherine J, LIEVENS, Yolande, RE, Allessandro, STAMATOULLAS, Aspasia, MORSCHHAUSER, Frank, LUGTENBURG, Pieternella J, ABRUZZESE, Elisabetta, OLIVIER, Pierre, CASASNOVAS, Rene-Olivier, FEDERICO, Massimo, VAN IMHOFF, Gustaaf, RAVELOARIVAHY, Tiana, BELLEI, Monica, VAN DER BORGHT, Thierry, BARDET, Stephane, VERSARI, Annibale, HUTCHINGS, Martin, MEIGNAN, Michel, FORTPIED, Catherine, GIRINSKY, Theodore, OUMEDALY, Reman, BRUSAMOLINO, Ercole, BRICE, Pauline, FERME, Christophe, VAN DER MAAZEN, Richard, GOTTI, Manuel

“…Combined-modality treatment is standard treatment for patients with clinical stage I/II Hodgkin lymphoma (HL). We hypothesized that an early positron emission…”
Get full text